Abstract
Tizanidine, a widely used muscle relaxant that can lower blood pressure, is metabolized by the cytochrome P450 1A2 (CYP1A2). We studied 1,626 patients prescribed tizanidine and 5,012 prescribed cyclobenzaprine concurrently with a strong CYP1A2 inhibitor. The primary outcome was severe hypotension, defined as systolic blood pressure (SBP) ≤ 70 mmHg during periods of drug co-exposure. Severe hypotension occurred more often in the tizanidine group (2.03%; n = 33) than the cyclobenzaprine group (1.28%; n = 64); odds ratio (OR) = 1.60; P = 0.029. This difference remained statistically significant after adjustment for a log-transformed propensity score that included age, sex, race, Charlson's comorbidity index, and concurrent use of antihypertensive medications (OR = 1.57; P = 0.049). A sensitivity analysis that defined hypotension as SBP < 90 mmHg also yielded higher rates of hypotension among patients prescribed tizanidine. In conclusion, CYP1A2 inhibition increases the risk of hypotensive episodes associated with the use of tizanidine in routine clinical practice.
References
Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Mar 1, 1996·British Journal of Clinical Pharmacology·U ChristiansK F Sewing
May 29, 1998·Circulation·P W WilsonW B Kannel
Feb 24, 2001·Journal of Child Neurology·T R Johnson, J D Tobias
Jul 18, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wen Xing PengHong Hao Zhou
Mar 5, 2004·British Journal of Clinical Pharmacology·Marika T GranforsPertti J Neuvonen
Apr 3, 2004·Clinical Pharmacology and Therapeutics·Marika T GranforsPertti J Neuvonen
Sep 24, 2004·The Annals of Pharmacotherapy·Chuen-Der KaoKwong-Kum Liao
Nov 13, 2004·Clinical Pharmacology and Therapeutics·Kenji MomoYukinao Kohda
Dec 14, 2004·Clinical Pharmacology and Therapeutics·Marika T GranforsPertti J Neuvonen
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Robert J GlynnTil Stürmer
Dec 21, 2006·Clinical Pharmacology and Therapeutics·Kenji MomoAkira Tamaoka
Feb 28, 2007·British Journal of Clinical Pharmacology·Satoko HoriYasufumi Sawada
Mar 6, 2008·European Journal of Clinical Pharmacology·Kenji MomoYukinao Kohda
May 27, 2008·Clinical Pharmacology and Therapeutics·D M RodenD R Masys
Jan 13, 2010·Journal of the American Medical Informatics Association : JAMIA·Hua XuJoshua C Denny
Sep 21, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Susan W Publow, Donald L Branam
Oct 25, 2014·Current Pharmaceutical Design·Aikaterini ZisakiVassily Hatzimanikatis
May 2, 2017·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Ana-Maria GheldiuMaria Neag
Citations
Sep 20, 2019·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Maureen C FarrellCyndya A Shibao
Sep 4, 2019·Hypertension·James M LutherJohn A Oates
Jan 7, 2021·European Journal of Clinical Pharmacology·Annette RudolphStefan Weiler
Jan 6, 2021·Current Drug Metabolism·Jingchao GuoXu Wang